Nuclear Receptor ROR-Gamma Market Report

Global and Region Nuclear Receptor ROR-Gamma Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：211
  • REPORT CODE：GMM912925
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nuclear Receptor ROR-Gamma market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nuclear Receptor ROR-Gammamarket, defines the market attractiveness level of Nuclear Receptor ROR-Gamma market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nuclear Receptor ROR-Gamma industry, describes the types of Nuclear Receptor ROR-Gamma market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nuclear Receptor ROR-Gamma market and the development prospects and opportunities of Nuclear Receptor ROR-Gamma industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nuclear Receptor ROR-Gamma market in Chapter 13.

    By Player:

    • Lead Pharma Holding BV

    • Advinus Therapeutics Ltd

    • Visionary Pharmaceuticals, Inc

    • Biogen, Inc

    • Karo Bio AB

    • 4SC AG

    • Celgene Corporation

    • Brickell Biotech, Inc

    • Teijin Pharma Limited

    • Phenex Pharmaceuticals AG

    • Hanmi Pharmaceuticals, Co Ltd

    • Genentech, Inc

    • Aurigene Discovery Technologies Limited

    • Nuevolution AB

    • Reata Pharmaceuticals, Inc

    • GlaxoSmithKline Plc

    • Vitae Pharmaceuticals, Inc

    • Genfit SA

    • Arrien Pharmaceuticals, LLC

    • Bristol-Myers Squibb Company

    By Type:

    • VPR-66

    • INV-17

    • GSK-2981278

    • BBI-6000

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nuclear Receptor ROR-Gamma Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nuclear Receptor ROR-Gamma Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nuclear Receptor ROR-Gamma Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nuclear Receptor ROR-Gamma Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nuclear Receptor ROR-Gamma Market Analysis and Outlook to 2022

    • 7.1 Global Nuclear Receptor ROR-Gamma Consumption (2017-2022)

    • 7.2 United States Nuclear Receptor ROR-Gamma Consumption (2017-2022)

    • 7.3 Europe Nuclear Receptor ROR-Gamma Consumption (2017-2022)

    • 7.4 China Nuclear Receptor ROR-Gamma Consumption (2017-2022)

    • 7.5 Japan Nuclear Receptor ROR-Gamma Consumption (2017-2022)

    • 7.6 India Nuclear Receptor ROR-Gamma Consumption (2017-2022)

    • 7.7 South Korea Nuclear Receptor ROR-Gamma Consumption (2017-2022)

    8 Region and Country-wise Nuclear Receptor ROR-Gamma Market Analysis and Outlook to 2028

    • 8.1 Global Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)

    • 8.2 United States Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)

    • 8.3 Europe Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)

    • 8.4 China Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)

    • 8.5 Japan Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)

    • 8.6 India Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)

    • 8.7 South Korea Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)

    9 Global Nuclear Receptor ROR-Gamma Market Outlook by Types and Applications to 2022

    • 9.1 Global Nuclear Receptor ROR-Gamma Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global VPR-66 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global INV-17 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global GSK-2981278 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global BBI-6000 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nuclear Receptor ROR-Gamma Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Nuclear Receptor ROR-Gamma Market Outlook by Types and Applications to 2028

    • 10.1 Global Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global VPR-66 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global INV-17 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global GSK-2981278 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global BBI-6000 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nuclear Receptor ROR-Gamma Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nuclear Receptor ROR-Gamma Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nuclear Receptor ROR-Gamma Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nuclear Receptor ROR-Gamma Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nuclear Receptor ROR-Gamma Market Competitive Analysis

    • 14.1 Lead Pharma Holding BV

      • 14.1.1 Lead Pharma Holding BV Company Details

      • 14.1.2 Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Product and Service

    • 14.2 Advinus Therapeutics Ltd

      • 14.2.1 Advinus Therapeutics Ltd Company Details

      • 14.2.2 Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Product and Service

    • 14.3 Visionary Pharmaceuticals, Inc

      • 14.3.1 Visionary Pharmaceuticals, Inc Company Details

      • 14.3.2 Visionary Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Visionary Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Product and Service

    • 14.4 Biogen, Inc

      • 14.4.1 Biogen, Inc Company Details

      • 14.4.2 Biogen, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Biogen, Inc Nuclear Receptor ROR-Gamma Product and Service

    • 14.5 Karo Bio AB

      • 14.5.1 Karo Bio AB Company Details

      • 14.5.2 Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Karo Bio AB Nuclear Receptor ROR-Gamma Product and Service

    • 14.6 4SC AG

      • 14.6.1 4SC AG Company Details

      • 14.6.2 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 4SC AG Nuclear Receptor ROR-Gamma Product and Service

    • 14.7 Celgene Corporation

      • 14.7.1 Celgene Corporation Company Details

      • 14.7.2 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Celgene Corporation Nuclear Receptor ROR-Gamma Product and Service

    • 14.8 Brickell Biotech, Inc

      • 14.8.1 Brickell Biotech, Inc Company Details

      • 14.8.2 Brickell Biotech, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Brickell Biotech, Inc Nuclear Receptor ROR-Gamma Product and Service

    • 14.9 Teijin Pharma Limited

      • 14.9.1 Teijin Pharma Limited Company Details

      • 14.9.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product and Service

    • 14.10 Phenex Pharmaceuticals AG

      • 14.10.1 Phenex Pharmaceuticals AG Company Details

      • 14.10.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product and Service

    • 14.11 Hanmi Pharmaceuticals, Co Ltd

      • 14.11.1 Hanmi Pharmaceuticals, Co Ltd Company Details

      • 14.11.2 Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Product and Service

    • 14.12 Genentech, Inc

      • 14.12.1 Genentech, Inc Company Details

      • 14.12.2 Genentech, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Genentech, Inc Nuclear Receptor ROR-Gamma Product and Service

    • 14.13 Aurigene Discovery Technologies Limited

      • 14.13.1 Aurigene Discovery Technologies Limited Company Details

      • 14.13.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product and Service

    • 14.14 Nuevolution AB

      • 14.14.1 Nuevolution AB Company Details

      • 14.14.2 Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Nuevolution AB Nuclear Receptor ROR-Gamma Product and Service

    • 14.15 Reata Pharmaceuticals, Inc

      • 14.15.1 Reata Pharmaceuticals, Inc Company Details

      • 14.15.2 Reata Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Reata Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Product and Service

    • 14.16 GlaxoSmithKline Plc

      • 14.16.1 GlaxoSmithKline Plc Company Details

      • 14.16.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product and Service

    • 14.17 Vitae Pharmaceuticals, Inc

      • 14.17.1 Vitae Pharmaceuticals, Inc Company Details

      • 14.17.2 Vitae Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Vitae Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Product and Service

    • 14.18 Genfit SA

      • 14.18.1 Genfit SA Company Details

      • 14.18.2 Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Genfit SA Nuclear Receptor ROR-Gamma Product and Service

    • 14.19 Arrien Pharmaceuticals, LLC

      • 14.19.1 Arrien Pharmaceuticals, LLC Company Details

      • 14.19.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product and Service

    • 14.20 Bristol-Myers Squibb Company

      • 14.20.1 Bristol-Myers Squibb Company Company Details

      • 14.20.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nuclear Receptor ROR-Gamma

    • Figure Nuclear Receptor ROR-Gamma Picture

    • Table Global Nuclear Receptor ROR-Gamma Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Receptor ROR-Gamma Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Receptor ROR-Gamma Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)

    • Figure United States Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)

    • Table Europe Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)

    • Figure China Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)

    • Figure Japan Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)

    • Figure India Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)

    • Figure Global Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)

    • Figure United States Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global VPR-66 Consumption and Growth Rate (2017-2022)

    • Figure Global INV-17 Consumption and Growth Rate (2017-2022)

    • Figure Global GSK-2981278 Consumption and Growth Rate (2017-2022)

    • Figure Global BBI-6000 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global VPR-66 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global INV-17 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GSK-2981278 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BBI-6000 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nuclear Receptor ROR-Gamma Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nuclear Receptor ROR-Gamma Export by Region (Top 5 Countries) (2017-2028)

    • Table Lead Pharma Holding BV (Foundation Year, Company Profile and etc.)

    • Table Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Product and Service

    • Table Advinus Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Product and Service

    • Table Visionary Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Visionary Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Visionary Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Product and Service

    • Table Biogen, Inc (Foundation Year, Company Profile and etc.)

    • Table Biogen, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen, Inc Nuclear Receptor ROR-Gamma Product and Service

    • Table Karo Bio AB (Foundation Year, Company Profile and etc.)

    • Table Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Karo Bio AB Nuclear Receptor ROR-Gamma Product and Service

    • Table 4SC AG (Foundation Year, Company Profile and etc.)

    • Table 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table 4SC AG Nuclear Receptor ROR-Gamma Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Nuclear Receptor ROR-Gamma Product and Service

    • Table Brickell Biotech, Inc (Foundation Year, Company Profile and etc.)

    • Table Brickell Biotech, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Brickell Biotech, Inc Nuclear Receptor ROR-Gamma Product and Service

    • Table Teijin Pharma Limited (Foundation Year, Company Profile and etc.)

    • Table Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product and Service

    • Table Phenex Pharmaceuticals AG (Foundation Year, Company Profile and etc.)

    • Table Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product and Service

    • Table Hanmi Pharmaceuticals, Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Product and Service

    • Table Genentech, Inc (Foundation Year, Company Profile and etc.)

    • Table Genentech, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech, Inc Nuclear Receptor ROR-Gamma Product and Service

    • Table Aurigene Discovery Technologies Limited (Foundation Year, Company Profile and etc.)

    • Table Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product and Service

    • Table Nuevolution AB (Foundation Year, Company Profile and etc.)

    • Table Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nuevolution AB Nuclear Receptor ROR-Gamma Product and Service

    • Table Reata Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Reata Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reata Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product and Service

    • Table Vitae Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Vitae Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vitae Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Product and Service

    • Table Genfit SA (Foundation Year, Company Profile and etc.)

    • Table Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genfit SA Nuclear Receptor ROR-Gamma Product and Service

    • Table Arrien Pharmaceuticals, LLC (Foundation Year, Company Profile and etc.)

    • Table Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US